Markus Müschen

1.5k total citations
20 papers, 884 citations indexed

About

Markus Müschen is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Markus Müschen has authored 20 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 12 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Markus Müschen's work include Acute Lymphoblastic Leukemia research (16 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Markus Müschen is often cited by papers focused on Acute Lymphoblastic Leukemia research (16 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Markus Müschen collaborates with scholars based in United States, Germany and Netherlands. Markus Müschen's co-authors include Patrice Douillard, Ulrich Warskulat, Yong‐Mi Kim, Dieter Häussinger, Emmanuelle Gilbert, Nora Heisterkamp, Régis Josien, C. Vignes, María Cristina Cuturi and Cécile Guillot and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

Markus Müschen

18 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Müschen United States 13 400 312 195 175 171 20 884
Lars Klemm United States 11 425 1.1× 185 0.6× 189 1.0× 246 1.4× 220 1.3× 34 818
Bruno A. Cardoso Portugal 14 434 1.1× 234 0.8× 230 1.2× 256 1.5× 250 1.5× 25 858
Antonia Busse Germany 19 495 1.2× 461 1.5× 567 2.9× 103 0.6× 180 1.1× 54 1.1k
Ugo Consoli Italy 17 367 0.9× 239 0.8× 395 2.0× 88 0.5× 257 1.5× 36 863
Yukiko Komeno Japan 20 549 1.4× 189 0.6× 112 0.6× 71 0.4× 445 2.6× 44 984
Yixiao Gong United States 10 574 1.4× 162 0.5× 189 1.0× 69 0.4× 285 1.7× 14 915
Timothy J. Ernst United States 7 494 1.2× 248 0.8× 286 1.5× 57 0.3× 188 1.1× 8 955
Michaela Prchal‐Murphy Austria 17 320 0.8× 383 1.2× 352 1.8× 37 0.2× 171 1.0× 30 900
Barbara Crescenzi Italy 18 344 0.9× 144 0.5× 207 1.1× 162 0.9× 476 2.8× 55 1.0k
Lisa Pleyer Austria 18 369 0.9× 204 0.7× 248 1.3× 115 0.7× 435 2.5× 53 947

Countries citing papers authored by Markus Müschen

Since Specialization
Citations

This map shows the geographic impact of Markus Müschen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Müschen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Müschen more than expected).

Fields of papers citing papers by Markus Müschen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Müschen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Müschen. The network helps show where Markus Müschen may publish in the future.

Co-authorship network of co-authors of Markus Müschen

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Müschen. A scholar is included among the top collaborators of Markus Müschen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Müschen. Markus Müschen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyons, Kent, Ilaria Iacobucci, Huimin Geng, et al.. (2024). Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia. Blood. 144(Supplement 1). 1446–1446.
2.
Ogana, Heather, Chih‐Lin Hsieh, Huimin Geng, et al.. (2023). Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia. Frontiers in Cell and Developmental Biology. 11. 1134121–1134121. 2 indexed citations
3.
Chan, Lai N., Christian Hurtz, Etienne Léveillé, et al.. (2021). Identification of BCL6 As Synthetic Lethality in RAS-Driven B-Cell Transformation. Blood. 138(Supplement 1). 792–792. 1 indexed citations
4.
Cosgun, Kadriye Nehir, Xin Yang, Ali Aghajanirefah, et al.. (2017). Lgr5 Functions As Negative Regulator of Wnt Signaling in B Cells and Is Critical for Self-Renewal of Normal and Transformed B Cells. Blood. 130. 3989–3989. 2 indexed citations
5.
Heltemes-Harris, Lynn, Mark Willette, Christine Henzler, et al.. (2017). Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nature Immunology. 18(6). 694–704. 63 indexed citations
6.
Fang, Mimi, Dawne N. Shelton, Hongxing Yang, et al.. (2017). Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia. Blood. 129(22). 3000–3008. 42 indexed citations
7.
Schjerven, Hilde, Ali Aghajanirefah, Jami McLaughlin, et al.. (2017). Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre–B ALL. The Journal of Experimental Medicine. 214(3). 793–814. 28 indexed citations
8.
Ghosh, Dipanjan, Mariela Sivina, Stefan Koehrer, et al.. (2016). Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 174(3). 425–436. 29 indexed citations
9.
Gang, Eun Ji, Jennifer Pham, Yi Zhao, et al.. (2013). Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Oncogene. 33(17). 2169–2178. 132 indexed citations
10.
Hurtz, Christian, Huimin Geng, Erica Ballabio, et al.. (2013). Identification Of BCL6 As a Therapeutic Target In MLL-Rearranged ALL. Blood. 122(21). 72–72. 1 indexed citations
11.
Ramezani-Rad, Parham, Huimin Geng, Christian Hurtz, et al.. (2012). SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood. 121(1). 148–155. 64 indexed citations
12.
Park, Eugene, Eun Ji Gang, Paul Schaefer, et al.. (2011). Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood. 118(8). 2191–2199. 90 indexed citations
13.
Parameswaran, Reshmi, Markus Müschen, Yong‐Mi Kim, John Groffen, & Nora Heisterkamp. (2010). A Functional Receptor for B-Cell–Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias. Cancer Research. 70(11). 4346–4356. 46 indexed citations
14.
Duy, Cihangir, Mieke Sprangers, Lars Klemm, et al.. (2009). Inactivation of Pre-B Cell Receptor-Mediated Tumor Suppression by Aberrant Splicing in Ph+ Acute Lymphoblastic Leukemia.. Blood. 114(22). 579–579. 1 indexed citations
15.
Feldhahn, Niklas, Nadine Henke, Cihangir Duy, et al.. (2007). Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1–transformed acute lymphoblastic leukemia cells. The Journal of Experimental Medicine. 204(5). 1157–1166. 70 indexed citations
16.
Klein, Florian, Niklas Feldhahn, Jana L. Mooster, et al.. (2005). Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion, and IGL Gene Rearrangement. The Journal of Immunology. 174(1). 367–375. 34 indexed citations
17.
Klein, Florian, Niklas Feldhahn, Jana L. Mooster, Peter Wernet, & Markus Müschen. (2004). Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion and IGL Gene Rearrangement.. Blood. 104(11). 315–315. 2 indexed citations
18.
Müschen, Markus, et al.. (1999). Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology. 116(3). 666–677. 63 indexed citations
19.
Josien, Régis, Patrice Douillard, Cécile Guillot, et al.. (1998). A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.. Journal of Clinical Investigation. 102(11). 1920–1926. 132 indexed citations
20.
Müschen, Markus, Ulrich Warskulat, Patrice Douillard, Emmanuelle Gilbert, & Dieter Häussinger. (1998). Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology. 27(1). 200–208. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Klemm Breakdown of academic impact, for papers by Bruno A. Cardoso Breakdown of academic impact, for papers by Antonia Busse Breakdown of academic impact, for papers by Ugo Consoli Breakdown of academic impact, for papers by Yukiko Komeno Breakdown of academic impact, for papers by Yixiao Gong Breakdown of academic impact, for papers by Timothy J. Ernst Breakdown of academic impact, for papers by Michaela Prchal‐Murphy Breakdown of academic impact, for papers by Barbara Crescenzi Breakdown of academic impact, for papers by Lisa Pleyer
Rankless by CCL
2026